Leveraging chorionic villus biopsies for the derivation of patient-specific trophoblast stem cells

Human trophoblast stem (TS) cells are an informative in vitro model for the generation and testing of biologically meaningful hypotheses. The goal of this project was to derive patient-specific TS cell lines from clinically available chorionic villus sampling (CVS) biopsies. Cell outgrowths were captured from human CVS tissue specimens cultured in modified human TS cell medium. Cell colonies emerged early during the culture and cell lines were established and passaged for several generations. Karyotypes of the newly established CVS-derived trophoblast stem (TSCV) cell lines were determined and compared to initial genetic diagnoses from freshly isolated chorionic villi. Phenotypes of TSCV cells in the stem state and following differentiation were compared to cytotrophoblast-derived TS (TSCT) cells. TSCV and TSCT cells uniformly exhibited similarities in the stem state and following differentiation into syncytiotrophoblast. These shared features included morphology and gene expression. TSCV cell differentiation into extravillous trophoblast cells exhibited cell line dependent phenotypes. CVS tissue specimens provide a valuable source for TS cell derivation. They expand the genetic diversity of available TS cells and are associated with defined clinical outcomes. TSCV cell lines provide a new set of experimental tools for investigating trophoblast cell lineage development.

[1]  J. Hanna,et al.  Human primed and naïve PSCs are both able to differentiate into trophoblast stem cells , 2022, Stem cell reports.

[2]  C. Fiala,et al.  Transforming growth factor-β signaling governs the differentiation program of extravillous trophoblasts in the developing human placenta , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Cheong,et al.  Functional antagonism between ΔNp63α and GCM1 regulates human trophoblast stemness and differentiation , 2022, Nature Communications.

[4]  Wenjun Wang,et al.  Derivation of human triploid trophoblast stem cells , 2022, Journal of Assisted Reproduction and Genetics.

[5]  K. Shirahige,et al.  Highly rigid H3.1/H3.2–H3K9me3 domains set a barrier for cell fate reprogramming in trophoblast stem cells , 2022, Genes & development.

[6]  E. Grundberg,et al.  Intersection of regulatory pathways controlling hemostasis and hemochorial placentation , 2021, Proceedings of the National Academy of Sciences.

[7]  S. Marsh,et al.  Characterization of primary models of human trophoblast , 2021, Development.

[8]  Bum-Kyu Lee,et al.  Induction of human trophoblast stem-like cells from primed pluripotent stem cells , 2021, bioRxiv.

[9]  J. Aplin,et al.  Cell dynamics in human villous trophoblast. , 2021, Human reproduction update.

[10]  H. Tseng,et al.  Sex differences in microRNA expression in first and third trimester human placenta , 2021, Biology of Reproduction.

[11]  P. Lavoie,et al.  Cell trajectory modeling identifies a primitive trophoblast state defined by BCAM enrichment , 2021, bioRxiv.

[12]  W. Robinson,et al.  Mistakes Are Common; Should We Worry about Them? , 2021, Trends in molecular medicine.

[13]  J. Nichols,et al.  Naive stem cell blastocyst model captures human embryo lineage segregation , 2021, Cell stem cell.

[14]  Matthew D. Young,et al.  Inherent mosaicism and extensive mutation of human placentas , 2021, Nature.

[15]  H. Tseng,et al.  High-throughput miRNA-sequencing of the human placenta: expression throughout gestation , 2021, bioRxiv.

[16]  K. Mechtler,et al.  MSX2 safeguards syncytiotrophoblast fate of human trophoblast stem cells , 2021, Proceedings of the National Academy of Sciences.

[17]  I. Okamoto,et al.  Capturing Human Trophoblast Development with Naïve Pluripotent Stem Cells In Vitro , 2020, bioRxiv.

[18]  G. Burton,et al.  BAP1/ASXL complex modulation regulates epithelial-mesenchymal transition during trophoblast differentiation and invasion , 2020, bioRxiv.

[19]  Stéphanie Kilens,et al.  Induction of Human Trophoblast Stem Cells from Somatic Cells and Pluripotent Stem Cells. , 2020, Cell reports.

[20]  S. Kimber,et al.  Trophectoderm differentiation to invasive syncytiotrophoblast is promoted by endometrial epithelial cells during human embryo implantation , 2020, bioRxiv.

[21]  T. Arima,et al.  Unique features and emerging in vitro models of human placental development , 2020, Reproductive medicine and biology.

[22]  M. Zernicka-Goetz,et al.  Developmental potential of aneuploid human embryos cultured beyond implantation , 2020, Nature Communications.

[23]  C. Farber,et al.  Sexually dimorphic crosstalk at the maternal-fetal interface. , 2020, The Journal of clinical endocrinology and metabolism.

[24]  S. Gunewardena,et al.  TEAD4 ensures postimplantation development by promoting trophoblast self-renewal: An implication in early human pregnancy loss , 2020, Proceedings of the National Academy of Sciences.

[25]  William A. Pastor,et al.  Naive Human Embryonic Stem Cells Can Give Rise to Cells with a Trophoblast-like Transcriptome and Methylome , 2020, Stem cell reports.

[26]  M. Islam,et al.  Atypical protein kinase C iota (PKCλ/ι) ensures mammalian development by establishing the maternal–fetal exchange interface , 2020, Proceedings of the National Academy of Sciences.

[27]  V. Dumeaux,et al.  Histone deacetylase 1 and 2 drive differentiation and fusion of progenitor cells in human placental trophoblasts , 2020, Cell Death & Disease.

[28]  J. Nichols,et al.  Human Naïve Epiblast Cells Possess Unrestricted Lineage Potential , 2020, bioRxiv.

[29]  W. Dean,et al.  Mechanisms of early placental development in mouse and humans , 2019, Nature Reviews Genetics.

[30]  M. Suyama,et al.  Zfp281 Shapes the Transcriptome of Trophoblast Stem Cells and Is Essential for Placental Development. , 2019, Cell reports.

[31]  J. James,et al.  Human placenta and trophoblast development: key molecular mechanisms and model systems , 2019, Cellular and Molecular Life Sciences.

[32]  M. Soares,et al.  Hemochorial placentation: development, function, and adaptations† , 2018, Biology of Reproduction.

[33]  M. Suyama,et al.  Derivation of Human Trophoblast Stem Cells. , 2018, Cell stem cell.

[34]  M. Hemberger,et al.  From the stem of the placental tree: trophoblast stem cells and their progeny , 2016, Development.

[35]  J. Rossant,et al.  What Is Trophoblast? A Combination of Criteria Define Human First-Trimester Trophoblast , 2016, Stem cell reports.

[36]  S. Shim,et al.  Chorionic villus sampling. , 1997, Obstetrics and gynecology clinics of North America.

[37]  J. Rossant,et al.  Developmental differences in the expression of FGF receptors between human and mouse embryos. , 2014, Placenta.

[38]  M. T. Moura.  PLURIPOTENCY AND CELLULAR REPROGRAMMING , 2013 .

[39]  K. Plath,et al.  Epigenetics of Reprogramming to Induced Pluripotency , 2013, Cell.

[40]  N. Wake,et al.  FGF4-dependent stem cells derived from rat blastocysts differentiate along the trophoblast lineage. , 2011, Developmental biology.

[41]  R. Yuen,et al.  Review: A high capacity of the human placenta for genetic and epigenetic variation: implications for assessing pregnancy outcome. , 2011, Placenta.

[42]  Krishanu Saha,et al.  Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues , 2010, Cell.

[43]  M. Pisarska,et al.  Prevalence of chromosomal mosaicism in pregnancies from couples with infertility. , 2009, Fertility and sterility.

[44]  B. Brambati,et al.  Chorionic villus sampling and amniocentesis , 2005, Current opinion in obstetrics & gynecology.

[45]  William Ho,et al.  Chorionic villi sampling: laboratory experience with 4,000 consecutive cases. , 1994, American journal of medical genetics.

[46]  John Williams,et al.  Transcervical CVS sample size: Correlation with placental location, cytogenetic findings, and pregnancy outcome , 1993, Prenatal Diagnosis.

[47]  J. Williams,et al.  Discrepancy in mosaic findings between chorionic villi and amniocytes: a diagnostic dilemma involving 45,X, 46,XY, and 47,XYY cell lines. , 1993, American journal of medical genetics.

[48]  B. Wang,et al.  Mosaicism in chorionic villus sampling: An analysis of incidence and chromosomes involved in 2612 consecutive cases , 1993, Prenatal diagnosis.

[49]  B. Wang,et al.  Chorionic Villus Sampling: Experience With 3016 Cases Performed by a Single Operator , 1992, Obstetrics and gynecology.

[50]  J. Strauss,et al.  In vitro systems for the study of human placental endocrine function. , 1990, Endocrine reviews.

[51]  M. Kaback,et al.  Chorionic villus sampling is associated with normal fetal growth. , 1987, American journal of obstetrics and gynecology.

[52]  Arthur T. Hertig.  THE HUMAN placenta. , 1970, What's new.

[53]  C. Heldin,et al.  Transforming Growth Factor-β Signaling , 2013 .

[54]  L. Shaffer,et al.  ISCN 2009 - An International System for Human Cytogenetic Nomenclature , 2009 .